ACADIA Pharmaceuticals Inc.

Q4 2023 13F Holders

Symbol
ACAD
CUSIP
004225108
Type
Equity
Class
COM
Num filings
303
Total reported value, excl. options
$5.08 B
Manager Report Date Value ($000) Shares Option Type